CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

Bas J. M. Peters; Ankie M. Harmsze; Jurriën M. ten Berg; Anke-Hilse Maitland-van der Zee; Mathieu M. Tjoeng; Anthonius de Boer; Vera H. M. Deneer

doi:10.2217/pgs.10.211

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

Bas J. M. Peters
, Ankie M. Harmsze
, Jurriën M. ten Berg
, Anke-Hilse Maitland-van der Zee
, Mathieu M. Tjoeng
, Anthonius de Boer
, Vera H. M. Deneer

pre-AMC

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	141-144
Journal	Pharmacogenomics
Volume	12
Issue number	2
DOIs	https://doi.org/10.2217/pgs.10.211
Publication status	Published - 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2217/pgs.10.211

Cite this

@article{5e1173fa98674236b634c013722f9524,

title = "CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel",

author = "Peters, \{Bas J. M.\} and Harmsze, \{Ankie M.\} and \{ten Berg\}, \{Jurri{\"e}n M.\} and \{Maitland-van der Zee\}, Anke-Hilse and Tjoeng, \{Mathieu M.\} and \{de Boer\}, Anthonius and Deneer, \{Vera H. M.\}",

year = "2011",

doi = "10.2217/pgs.10.211",

language = "English",

volume = "12",

pages = "141--144",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "2",

}

TY - JOUR

T1 - CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

AU - Peters, Bas J. M.

AU - Harmsze, Ankie M.

AU - ten Berg, Jurriën M.

AU - Maitland-van der Zee, Anke-Hilse

AU - Tjoeng, Mathieu M.

AU - de Boer, Anthonius

AU - Deneer, Vera H. M.

PY - 2011

Y1 - 2011

U2 - 10.2217/pgs.10.211

DO - 10.2217/pgs.10.211

M3 - Editorial

C2 - 21332306

SN - 1462-2416

VL - 12

SP - 141

EP - 144

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 2

ER -